With this approach, FGFR3, PDGFRA, APC, RET, ATM and TP53 were flagged; however, experience in the larger lung adenocarcinoma cohort (Table 3) may call into question the reliability of the former 4 genes, Table 4. This evidence concerns the gene FGFR3 and lung adenocarcinoma.